MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21

Cancer Medicine

Volumn 5, Issue 12, 2016, Pages 3489-3499

  Chen, Chun ^a   Lu, Zenghong ^b   Yang, Jie ^c   Hao, Weichao ^c   Qin, Yujuan ^c   Wang, Huiyan ^c   Xie, Congying ^a   Xie, Raoying ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; miR 17 5p; nasopharyngeal carcinoma; p21; poor prognosis

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 17; PROTEIN P21; UNCLASSIFIED DRUG; MIRN17 MICRORNA, HUMAN; P21 ACTIVATED KINASE; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL LINE; CANCER CLASSIFICATION; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE ASSAY; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; KAPLAN MEIER METHOD; MOUSE; MTT ASSAY; NASOPHARYNX CARCINOMA; NONHUMAN; NUDE MOUSE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; 3' UNTRANSLATED REGION; ANIMAL; CARCINOMA; CELL TRANSFORMATION; DISEASE MODEL; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; P21-ACTIVATED KINASES; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84997525232     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.863     Document Type: Article

References (43)

1. Wei, W. I., and J. S. Sham. 2005. Nasopharyngeal carcinoma. The Lancet 365:2041–2054.
2. Bei, J. X., Y. Li, W. H. Jia, B. J. Feng, G. Zhou, et al. 2010. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat. Genet. 42:599–603.
3. Raab-Traub, N. 2002. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12:431–441.
4. Fang, C. Y., S. Y. Huang, C. C. Wu, H. Y. Hsu, S. P. Chou, et al. 2012. The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells. PLoS ONE 7:e44810.
5. Valencia-Sanchez, M. A., J. Liu, G. J. Hannon, and R. Parker. 2006. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20:515–524.
6. Yekta, S., I. H. Shih, and D. P. Bartel. 2004. MicroRNA-directed cleavage of HOXB8 mRNA. Science 304:594–596.
7. Zhang, B. G., J. F. Li, B. Q. Yu, Z. G. Zhu, B. Y. Liu, et al. 2012. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol. Rep. 27:1019–1026.
8. Lonnroth, C., M. Andersson, A. G. Asting, S. Nordgren, and K. Lundholm. 2014. Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer. Int. J. Oncol. 45:2208–2220.
9. Gong, C., S Qu, Y Nie, J. Y. Liao, X. Cui, et al. 2014. miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors. Cancer Res. 74:4341–4352.
10. Othman, N., and N. H. Nagoor. 2014. The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatment. Biomed. Res. Int. 2014:318030.
11. Yu, J., K. Ohuchida, K. Mizumoto, H. Fujita, K. Nakata, et al. 2010. MicroRNa miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol. Ther. 10:748–757.
12. Wang, M., H. Gu, S. Wang, H. Qian, W. Zhu, et al. 2012. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol. Med. Rep. 5:1514–1520.
13. Ren, H. L., Y. Sun, X. N. Li, H. L. Hu, S. B. Li, et al. 2011. Expression of E2F3, miR-17-5p, miR-20a and their interplay in bladder cancer. Afr. J. Biotechnol. 10:11028–11032.
14. Yang, F., Y. Yin, F. Wang, Y. Wang, L. Zhang, et al. 2010. miR-17-5p promotes migration of human hepatocellular carcinoma cells through the P38 mitogen-activated protein kinase-heat shock protein 27 pathway. Hepatology 51:1614–1623.
15. Hossain, A., M. T. Kuo, and G. F. Saunders. 2006. miR-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell. Biol. 26:8191–8201.
16. Chen, Q., Q. Si, S. Xiao, Q. Xie, J. Lin, et al. 2013. Prognostic significance of serum miR-17-5p in lung cancer. Med. Oncol. 30:353.
17. Wei, Q., Y. X. Li, M. Liu, X. Li, and H. Tang. 2012a. Mir-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life 64:697–704.
18. Cloonan, N., M. K. Brown, A. L. Steptoe, S. Wani, W. L. Chan, et al. 2008. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol. 9:R127.
19. Luo, Z., Y. Dai, L. Zhang, C. Jiang, Z. Li, J. Yang, et al. 2013a. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis 34:415–425.
20. Chen, H. C., G. H. Chen, Y. H. Chen, W. L. Liao, C. Y. Liu, et al. 2009. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br. J. Cancer 100:1002–1011.
21. Zeng, X., J. Xiang, M. Wu, W. Xiong, H. Tang, et al. 2012. Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS ONE 7:e46367.
22. Abbas, T., and A. Dutta. 2009. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 9:400–414.
23. Chen, Y., S. Bian, J. Zhang, H. Zhang, B. Tang, et al. 2014. The silencing effect of microRNA miR-17 on p21 maintains the neural progenitor pool in the developing cerebral cortex. Front Neurol. 5:132.
24. Wong, P., M. Iwasaki, T. C. Somervaille, and F. Ficara et al. 2010. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.Cancer Res. 70: 3833–3842.
25. He, M., Q. Y. Wang, Q. Q. Yin, J. Tang, Y. Lu, et al. 2012. HIF-1α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation. Cell Death Differ. 20:408–418.
26. Minami, Y., S. Kohsaka, M. Tsuda, K. Yachi, N. Hatori, et al. 2014. SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1. Cancer Sci. 105:1152–1159.
27. Xie, X., O. P. F. Clausen, and M. Boysen. 2002. prognostic significance of p21WAFI/CHIP expression in tongue squamous cell carcinomas. Arch. Otolaryngol. Head Neck Surg. 128:897–902.
28. Green, A. R., F. F. Barros, T. M. Abdel-Fatah, P. Moseley, C. C. Nolan, et al. 2014. HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2 + breast cancer. Breast Cancer Res. Treat. 145:33–44.
29. Sim, S. H., M. H. Kang, Y. J. Kim, K. W. Lee, D. W. Kim, et al. 2014. p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer. BMC Cancer 14:241.
30. Park, P., J. Kim, J. K. Park, S. Huang, S. Y. Kwak, et al. 2014. Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer. Head Neck 37:953–963.
31. Xie, R., X. Lin, T. Du, K. Xu, H. Shen, et al. 2016. Targeted disruption of miR-17-92 impairs mouse Spermatogenesis by activating mTOR signaling pathway. Medicine (Baltimore) 95:e2713.
32. Lyu, X., W. Fang, L. Cai, H. Zheng, Y. Ye, et al. 2014. TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness. Mol. Cancer. 8:51.
33. Zhang, Y., L. Zheng, J. Huang, F. Gao, X. Lin, et al. 2014. MiR-124 Radiosensitizes human colorectal cancer cells by targeting PRRX1. PLoS ONE 9:e93917.
34. Wei, F., X. X. Rong, R. Y. Xie, L. T. Jia, H. Y. Wang, et al. 2015. Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition. Oncotarget 6:35023–35039.
35. Luo, W., S. Li, B. Peng, Y. Ye, and X. Deng. 2013b. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. PLoS ONE 8:e56324.
36. Zhao, W. Y., Y. Wang, Z. J. An, C. G. Shi, G. A. Zhu, et al. 2013. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer. Biochem. Biophys. Res. Commun. 435:466–471.
37. Bonauer, A., and S. Dimmeler. 2009. The microRNA-17~92 cluster. Cell Cycle 8:3866–3873.
38. van Haaften, G., and R. Agami. 2010. Tumorigenicity of the miR-17-92 cluster distilled. Genes Dev. 24:1–4.
39. Campisi, J. 2003. Cancer and ageing: rival demons? Nat. Rev. Cancer 3:339–349.
40. Wei, Q., Y. X. Li, M. Liu, X. Li, and H. Tang. 2012b. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life 64:697–704.
41. Yan, H. L., G. Xue, Q. Mei, Y. Z. Wang, F. X. Ding, et al. 2009. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 28:2719–2732.
42. Viale, A., F. De Franco, A. Orleth, V. Cambiaghi, V. Giuliani, et al. 2009. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 457:51–56.
43. O'Brien, C. A., A. Kreso, P. Ryan, K. G. Hermans, L. Gibson, et al. 2012. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell 21:777–792.